Advertisement

Herpes Simplex Virus (HSV) Diseases of the Anterior Segment and the Adnexa

  • Rainer Sundmacher

Abstract

• In viral herpetic diseases, replicating HSV can be isolated from the affected structures and antiviral treatment is always the basis of therapy.

• In metaherpetic diseases, i. e., in non-viral healing disorders after preceding viral disease, antiviral therapy increases the healing problems and is, therefore, mostly contraindicated.

Keywords

Herpes Simplex Virus Herpes Simplex Virus Infection Herpetic Keratitis Stromal Keratitis Herpetic Stromal Keratitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Holland EJ, Schwartz GS (1999) Classification of herpes simplex virus keratitis. Cornea 18: 144–154 PubMedGoogle Scholar
  2. Liesegang TJ (1999) Classification of herpes simplex virus keratitis and anterior uveitis. Cornea 18: 127–143 PubMedGoogle Scholar
  3. Sundmacher R (1981) A clinico-virologic classification of herpetic anterior segment diseases with special reference to intraocular herpes. In: R Sundmacher (ed) Herpetic Eye Diseases. Bergmann, Munich, pp 203–208 Google Scholar
  4. Sundmacher R (1987) Clinical aspects of herpetic eye diseases. Current Eye Res 6: 183–188 Google Scholar
  5. Sundmacher R, Neumann-Haefelin D (1976) Keratitis metaherpetica. Klinische und virologische Befunde. Klin Monatsbl Augenheilk 169: 728–737 Google Scholar

Section 2.1

  1. Babu JS, Thomas J, Kanangat S, Morrison LA, Knipe DM, Rouse BT (1996) Viral replication is required for induction of ocular immunopathology by herpes simplex virus. J Virol 70: 101–107 PubMedGoogle Scholar
  2. Bak IJ, Markham CH, Cook ML, Stevens J (1977) Intraaxonal transport of herpes simplex virus in the rat central nervous system. Brain Res 136: 415–429 PubMedGoogle Scholar
  3. Banerjee K, Biswas PS, Kamaragurn U, Schoenberger SP, Rouse BT (2004) Protective and pathological roles of virus-specific and bystander CD8 + T cells in herpetic stromal keratitis. J Immunol 173: 7575–7583PubMedGoogle Scholar
  4. Buchman TG, Roizman B, Nahmias AJ (1979) Demonstration of exogenous reinfection with herpes simplex virus type-2 by restriction endonuclease fingerprinting of viral DNA. J Infect Dis 140: 295–304PubMedGoogle Scholar
  5. Carter C, Dyson H, Easty DL (1985) Herpes simplex virus infection of corneal cells in vitro. In: PC Maudgal, L Missotten (eds): Herpetic Eye Diseases. Doc Ophthalmol Progr Ser vol 44, Dr W Junk Publ., Dordrecht, pp 9–14Google Scholar
  6. Carter C, Easty DL (1981) The influence of antiviral immunity in epithelial herpetic keratitis. In: R. Sundmacher (ed): Herpetic Eye Diseases. Bergmann, Munich, pp 111–116Google Scholar
  7. Centifanto-Fitzgerald YM, Yamaguchi T, Kaufman HE, Togon M, Roizman B (1982) Ocular disease pattern induced by herpes simplex virus is genetically determined by a specific region of the viral DNA. J Exp Med 155: 475–489 PubMedGoogle Scholar
  8. Cook SD, Brown SM (1986) Herpes simplex virus type 1 persistence and latency in cultured rabbit corneal epithelial cells, keratocytes, and endothelial cells. Br J Ophthalmol 70: 642–650 PubMedGoogle Scholar
  9. Cook SD, Hill JH (1991) Herpes simplex virus: molecular biology and the possibility of corneal latency. Surv Ophthalmol 36: 140–148 PubMedGoogle Scholar
  10. Dawson CR, Togni B, Thygeson P (1966) Herpes simplex virus particles in the nerves of rabbit corneas after epithelial inoculation. Nature 211: 316–317PubMedGoogle Scholar
  11. Freeman ML, Sheridan BS, Bonneau RH, Hendricks RL (2007) Psychological stress compromises CD8 + T cell control of latent herpes simplex type 1 infections. J Immunol 179: 322–328PubMedGoogle Scholar
  12. Garweg JG, Halberstadt M (2002) Zur Pathogenese der herpetischen Keratitis. Klin Monatsbl Augenheilkd 219: 477–486 PubMedGoogle Scholar
  13. Hendricks RL, Janovicz M, Tumpey TM (1992) Critical role of corneal Langerhans cells in CD4- but not in CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas. J Immunol 148: 2522–2529 PubMedGoogle Scholar
  14. Hendricks RL, Tumpey TM (1991) Concurrent regeneration of T lymphocytes and susceptibility to HSV-1 corneal stromal disease. Curr Eye Res 10 (Suppl): 47–53 PubMedGoogle Scholar
  15. Herpetic Eye Disease Study Group (2000) Psychological stress and other potential triggers for recurrences of herpes simplex virus eye infections. Arch Ophthalmol 118: 1617–1625Google Scholar
  16. Holbach LM, Font RL, Wilhelmus KR (1991) Recurrent herpes simplex keratitis with concurrent epithelial and stromal involvement. Immunohistochemical and ultrastructural observations. Arch Ophthalmol 109: 692–695 PubMedGoogle Scholar
  17. Kaufmann HE, Azcuy AM, Varnell ED, Sloop GD, Thompson HW, Hill JM (2005) HSV-1 DNA in tears and saliva of normal adults. Invest Ophthalmol Vis Sci 46: 241–247 Google Scholar
  18. Kaye SB, Baker K, Bonshek , Maseruka H, Grinfeld E, Tullo A, Easty DL, Hart CA (2000) Human herpesviruses in the cornea. Br J Ophthalmol 84: 563–571PubMedGoogle Scholar
  19. Kaye SB, Lynas C, Patterson A, Risk JM, Mc Carthy K, Hart CA (1991) Evidence for herpes simplex viral latency in the human cornea. Br J Ophthalmol 75: 195–200 PubMedGoogle Scholar
  20. Kaye SB, Madan N, Dowd TC, Hart CA, Mc Carthy K, Patterson A (1990) Ocular shedding of herpes simplex virus. Br J Ophthalmol 74: 114–116 PubMedGoogle Scholar
  21. Koelle DM, Ghiasi H (2005) Prospects for developing an effective vaccine against herpes simplex virus infection. Curr Eye Res 30: 929–942PubMedGoogle Scholar
  22. Kwon SS, Gangarosa LP, Green K, Hill JM (1982) Kinetics of ocular herpes simplex virus shedding induced by epinephrine iontophoresis. Invest Ophthalmol Vis Sci 22: 818–821PubMedGoogle Scholar
  23. Lang A, Nikolich-Zugich J (2005) Development and migration of protective CD8 + T cells into the nervous system following ocular herpes simplex virus-1 infection. J Immunol 174: 2919–2925 PubMedGoogle Scholar
  24. Lenhard V, Haug P, Kirchner H, Hallermann C, Mattes A, Sundmacher R (1981) HLA phenotypes in patients with herpetic keratitis. In: R Sundmacher (ed) Herpetic eye disease. Bergmann, Munich, pp 95–97.Google Scholar
  25. Lewis ME, Leung WC, Jeffrey VM, Warren KG (1984) Detection of multiple strains of latent herpes simplex virus type 1 within individual human hosts. J Virol 52: 300–305PubMedGoogle Scholar
  26. Liesegang TJ (1989) Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 107: 1160–1165 PubMedGoogle Scholar
  27. Liesegang TJ (2001) Herpes simplex virus epidemiology and ocular importance. Cornea 20: 1–13 PubMedGoogle Scholar
  28. Martin RG, Dawson CR, Jones P, Togni B; Lyons C, Oh JO (1977) Herpesvirus in sensory and autonomic ganglia after eye infection. Arch Ophthalmol 95: 2053–2056 PubMedGoogle Scholar
  29. Mintsioulis G, Dawson CR, Oh JO, Briones O (1979) Herpetic eye disease in rabbits after inoculation of autonomic ganglia. Arch Ophthalmol 97: 1515–1517 PubMedGoogle Scholar
  30. Missotten L (1994) Immunology and herpetic keratitis. Eye 8: 12–21PubMedGoogle Scholar
  31. Mitchell BM, Bloom DC, Cohrs RJ, Gilden DH, Kennedy PG (2003) Herpes simplex virus-1 and varicella-zoster virus latency in ganglia. J Neurovirol 9: 194–204 PubMedGoogle Scholar
  32. Nesburn AB, Dickinson R, Radnotti M, Radnotti MT (1976) Experimental reactivation of ocular herpes simplex in rabbits. Surv Ophthalmol 21: 185 PubMedGoogle Scholar
  33. Neumann-Haefelin D, Lenz T, Sundmacher R (1979) Strain characteristics and features of ocular infection of herpes simplex virus type 1 isolates. Med Microbiol Immunol 167: 239–250 PubMedGoogle Scholar
  34. Neumann-Haefelin D, Sundmacher R (1981) Herpes viruses – common properties and heterogeneity. In: R Sundmacher (ed) Herpetic eye disease. Bergmann, Munich, pp 3–12Google Scholar
  35. Neumann-Haefelin D, Sundmacher R, Wochnik G, Bablok B (1978) Herpes simplex virus types 1 and 2 in ocular disease. Arch Ophthalmol 96: 64–69 PubMedGoogle Scholar
  36. Ohara PT, Chin MS, Vail JH (2000) The spread of herpes simplex virus type 1 from trigeminal neurons to the murine cornea: an immunoelectron microscopy study. J Virology 74: 4776–4786 Google Scholar
  37. Openshaw H, McNeill JI, Lin XH, Niland J, Cantin EM (1995) Herpes simplex virus DNA in normal corneas: persistence without viral shedding from ganglia. J Med Virol 46: 75–80PubMedGoogle Scholar
  38. Pavan-Langston D, Rong BL, Dunkel EC (1989) Extraneuronal herpetic latency: animal and human corneal studies. Acta Ophthalmol Suppl 192: 135–141 Google Scholar
  39. Pepose JS, Keadle TL, Morrison LA (2006) Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy. Am J Ophthalmol 141: 547–557 PubMedGoogle Scholar
  40. Posavad CM, Koelle DM, Corey L (1998) Tipping the scales of herpes simplex virus reactivation: the important responses are local. Nat Med 4: 381–382 PubMedGoogle Scholar
  41. Price RW, Katz BJ, Notkins AL (1975) Latent infection of the peripheral autonomic nervous system with herpes simplex virus. Nature 257: 686–688 PubMedGoogle Scholar
  42. Rager-Zisman B, Quan PC, Rosner M, Moller JR, Bloom BR (1987) Role of NK cells in protection of mice against herpes simplex virus-1 infection. J Immunol 138: 884–888 PubMedGoogle Scholar
  43. Remeijer L (2002) Human herpes simplex virus keratitis: The pathogenesis revisited. (Doctoral thesis, Erasmus University Rotterdam)Google Scholar
  44. Remeijer L, Maertzdorf J, Buitenwerf J, Osterhaus ADME, Verjans GMGM (2002) Corneal herpes simplex virus type 1 superinfection in patients with recrudescent herpetic keratitis. Invest Ophthalmol Vis Sci 43: 358–363 PubMedGoogle Scholar
  45. Sabagga EMH, Pavan-Langston D, Bean KM, Dunkel EC (1988) Detection of HSV nucleic acid sequences in the cornea during acute and latent ocular disease. Exp Eye Res 47: 545–553Google Scholar
  46. Severin M (1965) Die Hornhautsensibilität bei herpetischer Keratitis. Klin Monatsbl Augenheilkd 146: 683–695 PubMedGoogle Scholar
  47. Shimeld C, Hill TJ, Blyth WA, Easty DL (1990) Passive immunization protects the mouse eye from damage after herpes simples virus infection by limiting spread of virus in the nervous system. J Gen Virol 71: 681–687 PubMedGoogle Scholar
  48. Souza PM, Holland EJ, Huang AJ (2003) Bilateral herpetic keratoconjunctivitis. Ophthalmology 110: 493–496 PubMedGoogle Scholar
  49. Streilein JW, Dana R, Ksander BR (1997) Immunity causing blindness: five different paths to herpes stromal keratitis. Immunol Today 18: 443–449 PubMedGoogle Scholar
  50. Sundmacher R (1977) Die Pathophysiologie der Herpes simplex Rezidive. Klin Monatsbl Augenheilk 170: 613–621 Google Scholar
  51. Thomas J, Rouse BT (1997) Immunopathogenesis of herpetic ocular disease. Immunol Res 16: 375–386 PubMedGoogle Scholar
  52. Warren KG, Brown SM, Wroblewska Z, Gilden D, Koprowski H, Subak-Sharpe JH (1978) Isolation of latent herpes simplex virus from the superior cervical and vagus ganglions of human beings. N Engl J Med 289: 1068–1069 Google Scholar
  53. Wilhelmus KR, Falcon MG, Jones BR (1981) Bilateral herpetic keratitis. Br J Ophthalmol 65: 385–387 PubMedGoogle Scholar
  54. Wu L, Morahan PS (1992) Macrophages and other non specific defences: role in modulating resistance against herpes simplex virus. In: Rouse BT (ed). Herpes simplex virus: pathogenesis, immunobiology and control. Springer, Heidelberg/NY, pp 89–110Google Scholar

Section 2.2

  1. Colin J, Chastel C, Renard G, Cantell K (1983) Combination therapy for dendritic keratitis with human leukocyte interferon and acyclovir. Am J Ophthalmol 95: 346–348 PubMedGoogle Scholar
  2. Collum LM, Logan P, McAuliffe-Curtin D, Hung SO, Patterson A, Rees PJ (1985) Randomised double-blind trial of acyclovir (Zovirax) and adenine arabinoside in herpes simplex amoeboid corneal ulceration. Br J Ophthalmol 69: 847–850 PubMedGoogle Scholar
  3. Collum LM, McGettrick P, Akhtar J, Lavin J, Rees PJ (1986) Oral acyclovir (Zovirax) in herpes simplex dendritic corneal ulceration. Br J Ophthalmol 70: 435–438 PubMedGoogle Scholar
  4. Coster DJ, Jones BR, McGill JI (1979) Treatment of amoeboid herpetic ulcers with adenine arabinoside or trifluorothymidine. Br J Ophthalmol 63: 418–421 PubMedGoogle Scholar
  5. De Koning EW, van Bijsterveld OP, Cantell K (1982) Combination therapy for dendritic keratitis with human leukocyte interferon and trifluorothymidine. Br J Ophthalmol 66: 509–512 PubMedGoogle Scholar
  6. De Koning EW, van Bijsterveld OP, Cantell K (1983) Combination therapy for dendritic keratitis with acyclovir and alpha-interferon. Arch Ophthalmol 101: 1866–1868PubMedGoogle Scholar
  7. Hoh HB, Hurley C, Claoue C, Viswalingham M, Easty DL, Goldschmidt P, Collum LM (1996) Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study. Br J Ophthalmol 80: 140–143 PubMedGoogle Scholar
  8. Jones BR, Coster DJ, Falcon MG, Cantell K (1976) Topical therapy of ulcerative herpetic keratitis with human interferon. Lancet II: 128 Google Scholar
  9. La Lau C, Oosterhuis JA, Versteg J, van Rij G, Renardel de Lavalette JG, Craandijk A, Lamers WP, Lamers WP (1982) Acyclovir and trifluorothymidine in herpetic keratitis: a multicentre trial. Br J Ophthalmol 66: 506–508 PubMedGoogle Scholar
  10. Maudgal PC, De Clercq E (1991) Bromovinyldeoxyuridine treatment of herpetic keratitis clinically resistant to other antiviral agents. Curr Eye Res 10 Suppl: 193–199 PubMedGoogle Scholar
  11. Meurs PJ, van Bijsterveld OP (1985) Berofor Alpha 2 (r-Hu IFN-alpha 2 arg) und Aciclovir in der Behandlung der Herpes-Keratitis-dendritica. Klin Monatsbl Augenheilkd 187: 40–42 PubMedGoogle Scholar
  12. Neumann-Haefelin D, Mattes A, Sundmacher R (1981) Trifluorothymidine sensitivity of ocular herpes simplex strains. In: R Sundmacher (ed) Herpetic eye disease. Bergmann, Munich, pp 353–355Google Scholar
  13. Neumann-Haefelin D, Sundmacher R, Frey H. Merk W (1985) Recombinant HuIFN-gamma prevents herpes simplex keratitis in African green monkeys. Demonstration of synergism with recombinant HuIFN-alpha2. Med Microbiol Immunol 174: 81–86 PubMedGoogle Scholar
  14. Neumann-Haefelin D, Sundmacher R, Sauter B, Karges HE, Manthey KF (1975) Effect of human leukocyte interferon on vaccinia- and herpes virus-infected cell cultures and monkey corneas. Infect Immun 12: 148–155 PubMedGoogle Scholar
  15. Neumann-Haefelin D, Sundmacher R, Skoda R, Cantell K (1977) Comparative evaluation of human leukocyte and fibroblast interferon in the prevention of herpes simplex virus keratitis in a monkey model. Infect Immun 17: 468–470 PubMedGoogle Scholar
  16. Poirier RF (1985) Intraocular penetration of vidarabine monophosphate, trifluridine, and acyclovir. In: FC Blodi (ed) Herpes Simplex Infections of the Eye. Contemporary Issues in Ophthalmology vol 1. Churchill Livingstone, NY, pp 101–108 Google Scholar
  17. Power WJ, Benedict-Smith A, Hillery M, Brady K, Collum LM (1991) Randomised double-blind trial of bromovinyldeoxyuridine (BVDU) and trifluorothymidine (TFT) in dendritic corneal ulceration. Br J Ophthalmol 75: 649–651 PubMedGoogle Scholar
  18. Sundmacher R (1978) Trifluorthymidinprophylaxe bei der Steroidtherapie herpetischer Keratouveitiden. Klin Monatsbl Augenheilk 173: 516–519Google Scholar
  19. Sundmacher R (1982) A general summary of our interferon studies. In: H Shiota, Y Cheng, WH Prusoff (eds): Herpesviruses – clinical, pharmacological and basic aspects. Excerpta Medica Congress Series 571, Amsterdam, pp 308–310 Google Scholar
  20. Sundmacher R (1983) Orale Acyclovir-Therapie virologisch nachgewiesener intraokularer Herpes simplex Virus-Infektionen. Klin Monatsbl Augenheilk 183: 246–250 Google Scholar
  21. Sundmacher R (1983) Use of nucleoside analogues in the treatment of herpes simplex virus eye diseases. Metab Pediat Syst Ophthalmol 7: 89–94Google Scholar
  22. Sundmacher R (1984) The role of interferon in prophylaxis and treatment of dendritic keratitis. In: FC Blodi (ed): Contemporary issues in ophthalmology, vol 1: herpes simplex infections of the eye. Churchill Livingstone, NY, pp 129–146Google Scholar
  23. Sundmacher R (1985) Therapie der herpetischen Erkrankungen des vorderen Augenabschnitts. Klin Monatsbl Augenheilk 186: 421–423Google Scholar
  24. Sundmacher R (1988) Behandlung viraler Augenerkrankungen. In: OE Lund, TN Waubke (Hrsg): Neuerungen in der ophthalmologischen Diagnose und Therapie. Bücherei des Augenarztes 115: 90–93 Google Scholar
  25. Sundmacher R (1996) Therapie der Viruserkrankungen des vorderen Augenabschnittes. In: A Kampik, F Grehn (Hrsg): Das äußere Auge. Bücherei des Augenarztes. Enke, Stuttgart, 137: 121–126 Google Scholar
  26. Sundmacher R, Cantell K, Haug P, Neumann-Haefelin D (1978) Interferon Prophylaxe von Dendritica-Rezidiven bei lokaler Steroidtherapie. Ber Dtsch Ophthalmol Ges 75: 569–570Google Scholar
  27. Sundmacher R, Cantell K, Haug P, Neumann-Haefelin D (1978) Role of debridement and interferon in the treatment of dendritic keratitis. Albrecht von Graefes Arch Clin Exp Ophthalmol 207: 77–82 Google Scholar
  28. Sundmacher R, Cantell K, Horn C, Neumann-Haefelin D (1979) Kombinationstherapie der Keratitis dendritica mit Trifluorthymidin und Humanleukozyteninterferon. Ber Dtsch Ophthalmol Ges 76: 489–492Google Scholar
  29. Sundmacher R, Cantell K, Mattes A (1984) A combination therapy for dendritic keratitis. High-titer alpha-interferon and trifluorothymidine. Arch Ophthalmol 102: 554–555PubMedGoogle Scholar
  30. Sundmacher R, Cantell K, Neumann-Haefelin D (1978) Combination therapy of dendritic keratitis with trifluorothymidine and interferon. Lancet II: 687 Google Scholar
  31. Sundmacher R, Cantell K, Neumann-Haefelin D (1981) Evaluation of interferon in ocular viral diseases. In: E De Maeyer, G Galasso, H Schellekens (eds): The biology of the interferon system. Elsevier, Amsterdam, pp 343–350 Google Scholar
  32. Sundmacher R, Cantell K, Skoda R, Hallermann C, Neumann-Haefelin D (1987) Human leukocyte and fibroblast interferon in a combination therapy of dendritic keratitis. Albrecht von Graefes Arch Clin Exp Ophthalmol 208: 229–233 Google Scholar
  33. Sundmacher R, Mattes A, Neumann-Haefelin D, Adolf G, Kruss B (1987) The potency of interferon-alpha 2 and interferon-gamma in a combination therapy of dendritic keratitis. A controlled clinical study. Current Eye Res 6: 273–276 Google Scholar
  34. Sundmacher R, Neumann-Haefelin D, Cantell K (1976) Interferon treatment of dendritic keratitis. Lancet I: 1406–1407 Google Scholar
  35. Sundmacher R, Neumann-Haefelin D, Cantell K (1976) Successful treatment of dendritic keratitis with human leukocyte interferon. A controlled clinical study. Albrecht von Graefes Arch Clin Exp Ophthalmol 201: 39–45 Google Scholar
  36. Sundmacher R, Neumann-Haefelin D, Cantell K (1981) Therapy and prophylaxis of dendritic keratitis with topical human interferon. In: R Sundmacher (ed): Herpetic eye disease. Bergmann, Munich, pp 401–407Google Scholar
  37. Sundmacher R, Neumann-Haefelin D, Cantell K (1982) The clinical value of interferon in ocular viral disease. In: K Munk, H Kirchner (eds): Interferon – properties, mode of action, production, and clinical application. Karger, Basel, pp 191–196Google Scholar
  38. Sundmacher R, Neumann-Haefelin D, Manthey KF, Müller O (1976) Interferon in treatment of dendritic keratitis in humans. A preliminary report. J Infect Dis 133 (Suppl) A160–A164 PubMedGoogle Scholar
  39. Sundmacher R, Neumann-Haefelin D, Mattes A, Merk W, Adolf G, Cantell K (1985) Human leukocyte interferon plus trifluorothymidine versus recombinant alpha 2 arg interferon plus trifluorothymidine for therapy of dendritic keratitis. A controlled clinical study. In: PC Maudgal, L Missotten (eds): Herpetic Eye Diseases. Doc Ophthalmol Proc Ser 44. Dr W Junk Publ, Dordrecht, 359–366Google Scholar
  40. Sundmacher R, Neumann-Haefelin D, Shresta B (1975) Die Wirkung von Human-Leukozyten-Interferon (HIF) auf experimentelle Viruskeratitiden bei Affen. Albrecht von Graefes Arch Clin Exp Ophthalmol 195: 263–270 Google Scholar
  41. Tullo AB, Shimeld C, Blyth WA, Hill TJ, Easty DL (1983) Ocular infection with herpes simplex virus in non immune and immune mice. Arch Ophthalmol 101: 961–964PubMedGoogle Scholar
  42. Van Bijsterveld OP, Meurs PJ, de Clercq E, Maudgal PC (1989) Bromovinyldeoxyuridine and interferon treatment in ulcerative herpetic keratitis: a double masked study. Br J Ophthalmol 73: 604–607PubMedGoogle Scholar
  43. Weber U, Sundmacher R (1988) Die systemische Acyclovirtherapie herpetischer Sekundärglaukome. Fortschr Ophthalmol 85: 85–87 PubMedGoogle Scholar
  44. Wilhelmus KR (2000) The treatment of herpes simplex virus epithelial keratitis. Trans Am Ophthalmol Soc 98: 505–532 PubMedGoogle Scholar
  45. Yao YF, Inonue Y, Kase T, Uchihori Y, Mori Y, Ohashi Y (1996) Clinical characteristics of acyclovir-resistant herpetic keratitis and experimental studies of isolates. Albrecht von Graefes Arch Clin Exp Ophthalmol 234 Suppl 1: S126–S132 Google Scholar

Section 2.3

  1. Coster DJ, Welham RAN (1979) Herpetic canalicular obstruction. Brit J Ophthalmol 63: 259–262 Google Scholar
  2. De Koning EWJ, van Bijsterveld OP (1983) Herpes simplex virus canaliculitis. Ophthalmologica 186: 173–176 PubMedGoogle Scholar
  3. Easty D, Entwistle C, Funk A, Witcher J (1975) Herpes simplex keratitis and keratoconus in atopic patients. Trans Ophthalmol Soc UK 95: 267 PubMedGoogle Scholar
  4. Egerer I, Stary A (1980) Erosive ulcerative herpes simplex blepharitis. Arch Ophthalmol 98: 1760–1763 PubMedGoogle Scholar
  5. Forrest WM, Kaufman HE (1976) Zosteriform herpes simplex. Am J Ophthalmol 81: 86–88 PubMedGoogle Scholar
  6. Harris GJ, Hyndiuk RA, Fox MJ, Taugher PJ (1981) Herpetic canalicular obstruction. Arch Ophthalmol 99: 282–283 PubMedGoogle Scholar
  7. Harris GJ, Myers WG (1985) Herpetic canalicular obstruction. In: FC Blodi (ed) Herpes Simplex Infections of the Eye. Contemporary Issues in Ophthalmology vol 1. Churchill Livingstone, NY, pp 47–55Google Scholar
  8. Jakobiec FA, Dobli Srinivassan B, Gamboa ET (1979) Recurrent angular blepharitis in an adult. Am J Ophthalmol 88: 744–747 PubMedGoogle Scholar
  9. Kalman CM, Laskin OL (1986) Herpes zoster and zosteriform herpes simplex virus infections in immunocompetent adults. Am J Med 81: 775–778 PubMedGoogle Scholar
  10. Margolis TP, Ostler HB (1990) Treatment of ocular disease in eczema herpeticum. Am J Ophthalmol 110: 274–279 PubMedGoogle Scholar
  11. Prabripataloong T, Margolis TP, Lietman TM, Wong IG, Mather R, Gritz DC (2006) Atopic disease and herpes simplex eye disease: a population-based case-cohort study. Am J Ophthalmol 142: 745–749 Google Scholar
  12. Yamamoto S, Shimomura Y, Kinoshita S, Tano Y (1994) Differentiating zosteriform herpes simplex from ophthalmic zoster. Arch Ophthalmol 112: 1515–1516PubMedGoogle Scholar

Section 2.4

  1. Brown DC, Nesburn AB, Nauheim JS, Pavan-Langston D, Kaufman HE (1968) Recurrent herpes simplex conjunctivitis. Arch Ophthalmol 79: 733–735 PubMedGoogle Scholar
  2. Darougar S, Hunter PA, Viswalingham M, Gibson GA, Jones BR (1978) Acute follicular conjunctivitis and keratoconjunctivitis due to herpes simplex virus in London. Br J Ophthalmol 62: 843–849PubMedGoogle Scholar
  3. Easty DL, Tullo AB, Shimeld C, Hill TJ, Blyth WA (1985) The influence of prednisolone on external eye disease, virus proliferation and latent infection in an animal model of herpes simplex keratitis. In: PC Maudgal, L Missotten (eds.): Herpetic Eye Disease. W Junk, Dordrecht, pp 95–97Google Scholar
  4. Kaye SB, Madan N, Dowd TC, Hart CA, Mc Carthy K, Patterson A (1990) Ocular shedding of herpes simplex virus. Br J Ophthalmol 74: 114–116 PubMedGoogle Scholar
  5. Maggs DJ, Chang E, Nasisse MP, Mitchel WJ (1998) persistence of herpes simplex virus type 1 DNA in chronic conjunctival and eyelid lesions of mice. J Virol 72: 9166–9172 PubMedGoogle Scholar
  6. Nauheim JS (1969) Recurrent herpes simplex conjunctival ulceration. Arch Ophthalmol 81: 592–595 PubMedGoogle Scholar
  7. Sundmacher R (1986) Viruskonjunktivitis. Fortschr Ophthalmol 83: 257–262 PubMedGoogle Scholar
  8. Sundmacher R, Hillenkamp J, Reinhard T (2001) Therapie und Prophylaxe der Adenovirus-Keratokonjunktivitis. Ophthalmologe 98: 991–1009 PubMedGoogle Scholar
  9. Thiel MA, Bossart W, Bernauer W (1998) Clinical evaluation of impression cytology for the diagnosis of superficial viral eye diseases. Klin Monatsbl Augenheilkd 212: 388–391 PubMedGoogle Scholar
  10. Uchio E, Takeuchi S, Itoh N, Matsuura N, Ohno S, Aoki K (2000) Clinical and epidemiological features of acute follicular conjunctivitis with special reference to that caused by herpes simplex virus type 1. Br J Ophthalmol 84: 968–972 PubMedGoogle Scholar
  11. Wishart PK, James C, Wishart MS, Darougar S (1984) Prevalence of acute conjunctivitis caused by chlamydia, adenovirus, and herpes simplex virus in an ophthalmic casualty department. Br J Ophthalmol 68: 653–655PubMedGoogle Scholar

Section 2.5

  1. Carter C, Easty DL (1981) The influence of antiviral immunity in epithelial herpetic keratitis. In: R. Sundmacher (ed): Herpetic Eye Diseases. Bergmann, Munich, pp 111–116Google Scholar
  2. Collum LM, Logan P, McAuliffe-Curtin D, Hung SO, Patterson A, Rees PJ (1985) Randomised double-blind trial of acyclovir (Zovirax) and adenine arabinoside in herpes simplex amoeboid corneal ulceration. Br J Ophthalmol 69: 847–850 PubMedGoogle Scholar
  3. Connell PP, O´Reilly J, Coughlan S, Collum LM, Power WJ (2007) The role of common viral ocular pathogens in Thygeson´s superficial punctate keratitis. Br J Ophthalmol 91: 1038–1041 PubMedGoogle Scholar
  4. Coster DJ, Jones BR; Falcon MG (1977) Role of debridement in the treatment of herpetic keratitis. Trans Ophthalmol Soc UK 97: 314–317 PubMedGoogle Scholar
  5. Coster DJ, Jones BR, McGill JI (1979) Treatment of amoeboid herpetic ulcers with adenine arabinoside or trifluorothymidine. Br J Ophthalmol 63: 418–421 PubMedGoogle Scholar
  6. Easty DL, Tullo AB, Shimeld C, Hill TJ, Blyth WA (1985) The influence of prednisolone on external eye disease, virus proliferation and latent infection in an animal model of herpes simplex keratitis. In: PC Maudgal, L Missotten (eds.): Herpetic Eye Disease. W Junk, Dordrecht, pp 95–97 Google Scholar
  7. Herpetic Eye Disease Study Group (1997) A controlled trial of oral acyclovir for the prevention of stromal Keratitis or iritis in patients with herpes simplex virus epithelial keratitis. Arch Ophthalmol 115: 703–712 Google Scholar
  8. Müller LJ, Vrensen GFJM, Pels L, Nunes Cardozo B, Willekens B (1997) Architecture of human corneal nerves. Invest Ophthalmol Vis Sci 38: 985–994 PubMedGoogle Scholar
  9. Neumann-Haefelin D, Mattes A, Sundmacher R (1981) Trifluorothymidine sensitivity of ocular herpes simplex virus strains. In: R Sundmacher (ed) Herpetic Eye Diseases. Bergmann, Munich, pp 353–355 Google Scholar
  10. Reinhard T, Roggendorf M, Fengler I, Sundmacher R (2004) PCR for varicella zoster genome in corneal epithelial cells of patients with Thygesons superficial punctate Keratitis. Eye 18: 304–305PubMedGoogle Scholar
  11. Sundmacher R (1977) Bilaterale Pseudokeratitis dendritica (Richner-Hanhart-Syndrom). Klin Monatsbl Augenheilk 170: 84–88 Google Scholar
  12. Sundmacher R, Hillenkamp J, Reinhard T (2001) Therapie und Prophylaxe der Adenovirus-Keratokonjunktivitis. Ophthalmologe 98: 991–1009 PubMedGoogle Scholar
  13. Sundmacher R, Press M, Neumann-Haefelin D, Riede U (1977) Keratitis superficialis punctata Thygeson. Klin Monatsbl Augenheilk 170: 908–916 Google Scholar
  14. Tabery HM (1998) Early epithelial changes in recurrent herpes simplex virus keratitis. Acta Ophthalmol Scand 76: 349–352 PubMedGoogle Scholar
  15. Tullo AB, Shimeld C, Blyth WA, Hill TJ, Easty DL (1983) Ocular infection with herpes simplex virus in non immune and immune mice. Arch Ophthalmol 101: 961–964 PubMedGoogle Scholar
  16. Wilhelmus KR (2000) The treatment of herpes simplex virus epithelial keratitis. Trans Am Ophthalmol Soc 98: 505–532 PubMedGoogle Scholar
  17. Wilhelmus KR, Coster DH, Jones BR (1981) Acyclovir and debridement in the treatment of ulcerative herpetic keratitis. Am J Ophthalmol 91: 323–327 PubMedGoogle Scholar

Section 2.6

  1. Ahonen R, Vannas A, Mäkitie J (1984) Virus particles and leukocytes in herpes simplex keratitis. Cornea 3: 43–50 PubMedGoogle Scholar
  2. Babu JS, Thomas J, Kanagat S, Morrison LA, Knipe DM, Rouse BT (1996) Viral replication is required for induction of ocular immunopathology by herpes simplex virus. J Virol 70: 101–107 PubMedGoogle Scholar
  3. Banerjee K, Biswas PS, Kamaragurn U, Schoenberger SP, Rouse BT (2004) Protective and pathological roles of virus-specific and bystander CD8 + T cells in herpetic stromal keratitis. J Immunol 173: 7575–7583 PubMedGoogle Scholar
  4. Barney NP, Foster CS (1994) A prospective randomised trial for oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Cornea 13: 232–236 PubMedGoogle Scholar
  5. Brik D, Dunkel E, Pavan-Langston D (1994) Persistent herpes simplex virus in the corneal stroma despite topical and systemic antiviral therapy. Arch Ophthalmol 111: 1883–1896 Google Scholar
  6. Coster DJ (1978) Herpetic keratitis and corneal destruction. Trans Ophthalmol Soc UK 98: 372–376 PubMedGoogle Scholar
  7. Easty DL, Shimeld C, Claoue CMP, Menage M (1987) Herpes simplex virus isolation in chronic stromal keratitis: human and laboratory studies. Curr Eye Res 6: 69–74 PubMedGoogle Scholar
  8. Hendricks RL (1997) An immunologist´s view of herpes simplex keratitis: Thygeson lecture 1996. Cornea 16: 503–506 PubMedGoogle Scholar
  9. Hendricks RL, Tumpey TM (1990) Contribution of virus and immune factors to herpes simplex type-1 induced corneal pathology. Invest Ophthalmol Vis Sci 30: 1929–1939 Google Scholar
  10. Hendricks RL, Tumpey TM, Finnegan A (1992) IFN gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1 infected mice. J Immunol 149: 3023–3008 PubMedGoogle Scholar
  11. Herpetic Eye Disease Study Group (1994) A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmol 101: 1871–1882 Google Scholar
  12. Herpetic Eye Disease Study Group (1994) A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology 101: 1883–1896 Google Scholar
  13. Herpetic Eye Disease Study Group (1996) Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Br J Ophthalmol 80: 969–972 Google Scholar
  14. Holbach LM, Font RL, Baehr W, Pittler SJ (1991) HSV antigens and HSV DNA in avascular and vascularized lesions of human herpes simplex keratitis. Curr Eye Res 10 Suppl: 63–68 PubMedGoogle Scholar
  15. Holbach LM, Font RL, Nauman GOH (1990) Herpes simplex stromal and endothelial keratitis. Granulomatous cell reactions at the level of Descemet´s membrane, the stroma, and Bowman´s layer. Ophthalmology 97: 722–728 PubMedGoogle Scholar
  16. Johns KJ, O´Day DM, Head WS, Neff RJ, Elliott JH (1987) Herpes simplex masquerade syndrome: acanthamoeba Keratitis. Curr Eye Res 6: 207–212 PubMedGoogle Scholar
  17. Kaye SB, Baker K, Bonshek R, Maseruka H, Grinfeld E, Tullo A, Easty DL, Hart CA (2000) Human herpesviruses in the cornea. Br J Ophthalmol 84: 563–571 PubMedGoogle Scholar
  18. Kortüm GF, Seibel W, Völcker HE, Naumann GOH (1981) Zur Klinik der granulomatösen Reaktion gegn Descemetsche Membran. In: R Sundmacher (ed) Herpetic Eye Diseases. Bergmann, Munich, pp 163–166 Google Scholar
  19. Mathers WD, Goldberg MA, Sutphin JE, Ditkoff JW, Folberg R (1997) Coexistent Acanthamoeba keratitis and herpetic keratitis. Arch Ophthalmol 115: 714–718 PubMedGoogle Scholar
  20. Mauriello JA Jr, McLean IW, Riddle PJ (1995) Granulomatous reaction to Bowman´s layer in herpetic keratitis and band keratopathy. Can J Ophthalmol 30: 203–207 PubMedGoogle Scholar
  21. Metcalf JF, Kaufman HE (1976) Herpetic stromal keratitis – Evidence for cell-mediated immunopathogenesis. Am J Ophthalmol 82: 827–834 PubMedGoogle Scholar
  22. Metcalf JF, Hamilton DS, Reichert RW (1979) Herpetic keratitis in athymic (nude) mice. Infect Immune 26: 1164–1171 Google Scholar
  23. Meyers-Elliott RH, Chitjian PA (1981) Immunopathogenesis of corneal inflammation in herpes simplex virus stromal keratitis: role of the polymorphonuclear leucocyte. Invest Ophthalmol Vis Sci 20: 784–798PubMedGoogle Scholar
  24. Niemialtowski MG, Rouse BT (1992) Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J Immunol 149: 3035–3039 PubMedGoogle Scholar
  25. Sabbaga EM, Pavan-Langston D, Bean KM, Dunkel EC (1988) Detection of HSV nucleic acid sequences in the cornea during acute and latent ocular disease. Exp Eye Res 47: 545–553PubMedGoogle Scholar
  26. Seitzman GD, Strauss EC, Margolis TP (2006) “Steel wool keratopathy”: a clinical sign of chronic inflammation. Cornea 25: 742–744 PubMedGoogle Scholar
  27. Shimeld C, Tullo AB, Easty DL, Thomsit J (1982) Isolation of herpes simplex virus from the cornea in chronic stromal keratitis. Brit J Ophthalmol 66: 643–647 Google Scholar
  28. Streilein JW, Dana MR, Ksander BR (1997) Immunity causing blindness: five different paths to herpes stromal keratitis. Immunology Today 18: 443–449 Google Scholar
  29. Sundmacher R (1978) Trifluorthymidinprophylaxe bei der Steroidtherapie herpetischer Keratouveitiden. Klin Monatsbl Augenheilk 173: 516–519 Google Scholar
  30. Teitelbaum CS, Streeten BW, Dawson CR (1987) Histopathology of herpes simplex virus keratouveitis. Curr Eye Res 6: 189–194 PubMedGoogle Scholar
  31. Thomas J, Gangappa S, Kanangat S, Rouse BT (1997) On the essential involvement of neutrophils in the immunopathologic disease: Herpetic stromal keratitis. J Immunol 158: 1383–1391 PubMedGoogle Scholar
  32. Tullo AB, Easty DL, Hill TJ (1985) Isolation of herpes simplex virus from corneal discs of patients with chronic stromal keratitis. Trans Ophthalmol Soc UK 104: 159 PubMedGoogle Scholar
  33. Van Bijsterveld OP, Obster R (1983) Keratitis nummularis Dimmer, Morbus dubius. Klin Monatsbl Augenheilkd 183: 169–172 PubMedGoogle Scholar
  34. Wilhelmus KR, Coster DJ, Donovan HC, Falcon MG, Jones BR (1981) Prognosis indicators of herpetic keratitis. Analysis of a five-year observation period after corneal ulceration. Arch Ophthalmol 99: 1578–1582 PubMedGoogle Scholar
  35. Wilhelmus KR, Dawson CR, Barron BA, Bacchetti P, Gee L, Jones BR, Kaufman HE, Sugar J, Hyndiuk RA, Laibson PR, Stulting RD, Asbell PA (1996) Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Br J Ophthalmol 80: 969–972 PubMedGoogle Scholar
  36. Witschel H, Orsoni J (1981) Granulomatous keratitis and its relationship to herpetic disease. In: R Sundmacher (ed) Herpetic Eye Diseases. Bergmann, Munich, pp 167–173Google Scholar
  37. Witschel H, Sundmacher R, Seitz HM (1984) Amebic keratitis. A clinico-histopathologic case report. Klin Monatsbl Augenheilkd 185: 46–49 PubMedGoogle Scholar

Section 2.7

  1. Collin HB, Abelson MB (1976) Herpes simplex virus in human cornea, retrocorneal fibrous membrane and vitreous. Arch Ophthalmol 94: 1726–1729 PubMedGoogle Scholar
  2. Collum LMT, Grant DM (1987) A double-blind comparative trial of acyclovir and adenine arabinoside in combination with dilute betamethasone in the management of herpetic disciform keratitis. Curr Eye Res 6: 221–224 PubMedGoogle Scholar
  3. Hakin KN, Dart JK, Sherrard E (1989) Sporadic diffuse corneal endotheliitis. Am J Ophthalmol 108: 509–515PubMedGoogle Scholar
  4. Holbach LM, Asano N, Naumann GOH (1998) Infection of the corneal endothelium in herpes simplex keratitis. Am J Ophthalmol 126: 592–594 PubMedGoogle Scholar
  5. Holbach LM, Font RL, Nauman GOH (1990) Herpes simplex stromal and endothelial keratitis. Granulomatous cell reactions at the level of Descemet´s membrane, the stroma, and Bowman´s layer. Ophthalmology 97: 722–728 PubMedGoogle Scholar
  6. Oh JO (1970) Endothelial lesions of rabbit cornea produced by herpes simplex virus. Invest Ophthalmol Vis Sci 9: 196–205 Google Scholar
  7. Ohashi Y, Kinoshita S, Mano T, Kiritoshi A, Ohji M (1985) Idiopathic corneal endotheliopathy. A report of two cases. Arch Ophthalmol 103: 1666–1668 PubMedGoogle Scholar
  8. Ohashi Y, Yamamoto S, Hishida K (1991) Demonstration of herpes simplex virus DNA in idiopathic corneal endotheliopathy. Am J Ophthalmol 112: 419–423 PubMedGoogle Scholar
  9. Olsen TW, Hardten DR, Meiusi RS, Holland EJ (1994) Linear endotheliitis. Am J Ophthalmol 117: 468–474 PubMedGoogle Scholar
  10. Porter SM, Patterson A, Kho P (1990) A comparison of local and systemic acyclovir in the management of herpetic disciform keratitis. Br J Ophthalmol 74: 283–285 PubMedGoogle Scholar
  11. Robin JB, Steigner JB, Kaufman HE (1985) Progressive herpetic corneal endotheliitis. Am J Ophthalmol 100: 336–337PubMedGoogle Scholar
  12. Sundmacher R (1981) A clinico-virologic classification of herpetic anterior segment diseases with special reference to intraocular herpes. In: R Sundmacher (ed) Herpetic eye disease. Bergmann, Munich, pp 203–208 Google Scholar
  13. Sundmacher R (1983) Orale Acyclovir-Therapie virologisch nachgewiesener intraokularer Herpes simplex Virus-Infektionen. Klin Monatsbl Augenheilk 183: 246–250 Google Scholar
  14. Sundmacher R (1984) Endotheliitis corneae. Begriffsbestimmung and klinische Abgrenzung. Klin Monatsbl Augenheilk 184: 163–167Google Scholar
  15. Sundmacher R (1997) Diagnose und Differentialdiagnose der Endotheliitis und Trabekulitis. In: A Kampik, F Grehn (Hrsg): Entzündungen des Augeninnern. Bücherei des Augenarztes. Enke, Stuttgart, 138: 96–102 Google Scholar
  16. Sundmacher R, Neumann-Haefelin D (1979) Herpes simplex virus-positive and –negative keratouveitis. In: A Silverstein, R O´Connor (eds): Immunology and immunopathology of the eye. Masson, New York / Paris, pp 225–229 Google Scholar
  17. Sundmacher R, Neumann-Haefelin D (1979) Herpes-simplex-Virus-Isolierung aus dem Kammerwasser bei fokaler Iritis, Endotheliitis und langdauernder Keratitis disciformis mit Sekundärglaukom. Klin Monatsbl Augenheilk 175: 488–501 Google Scholar
  18. Sutcliffe E, Baum J (1984) Acute idiopathic corneal endotheliitis. Ophthalmology 91: 1161–1165 PubMedGoogle Scholar
  19. Vannas A, Ahonen R (1981) Herpetic endothelial keratitis. Acta Ophthalmol 59: 296 Google Scholar
  20. Vannas A, Ahonen R, Mäkitie J (1983) Corneal endothelium in herpetic keratouveitis. Arch Ophthalmol 101: 913–915 PubMedGoogle Scholar
  21. Witschel H, Sundmacher R (1980) Virusendotheliitis als Ursache konnataler Hornhauttrübungen. Ber Dtsch Ophthalmol Ges 77: 503–507 Google Scholar
  22. Zheng X, Yamaguchi M, Goto T, Okamoto S, Ohashi Y (2000) Experimental corneal endotheliitis in rabbit. Invest Ophthalmol Vis Sci 41: 377–385 PubMedGoogle Scholar

Section 2.8

  1. Alvarado JA, Underwood JL, Green WR, Wu S, Murphy CG, Hwang DG, Moore TE, O´Day D (1994) Detection of herpes simplex viral DNA in the iridocorneal endothelial syndrome. Arch Ophthalmol 112: 1601–1609 PubMedGoogle Scholar
  2. Amano S, Oshika T, Kaji Y, Numaga J, Matsubara M, Araie M (1999) Herpes simplex virus in the trabeculum of an eye with corneal endotheliitis. Am J Ophthalmol 127: 721–722 PubMedGoogle Scholar
  3. Dawson CR, Togni B, Moore TE (1968) Structural changes in chronic herpetic keratitis. Arch Ophthalmol 79: 740–747 PubMedGoogle Scholar
  4. Falcon MG, Williams HP (1978) Herpes simplex kerato-uveitis and glaucoma. Trans Ophthalmol Soc UK 98: 101–104PubMedGoogle Scholar
  5. Grehn F, Sundmacher R (1982) Zur Pathogenese und Therapie des Posner-Schlossman-Syndroms. In: G Krieglstein, W Leydhecker (eds): Medikamentöse Glaukomtherapie. Bergmann, Munich, pp 95–99Google Scholar
  6. Groh MI, Seitz B, Schumacher S, Naumann GOH (1999) Detection of herpes simplex virus in aqueous humor in iridocorneal endothelial (ICE) syndrome. Cornea 18: 359–360 PubMedGoogle Scholar
  7. Madjlessi F, Marx W, Reinhard T, Althaus C, Sundmacher R (2000) Impressions-Tonometrie und Applanations-Tonometrie bei pathologischen Hornhäuten im Vergleich mit der intraokularen Nadel-Druckmessung. Ophthalmologe 97: 478–481 PubMedGoogle Scholar
  8. Marx W, Madjlessi F, Reinhard T, Althaus C, Sundmacher R (1999) Mehr als vier Jahre Erfahrung mit der elektronischen intraokularen Nadel-Druckmessung bei irregulären Hornhäuten. Ein Erfahrungsbericht. Ophthalmologe 96: 498–502 PubMedGoogle Scholar
  9. Mitchell SM, Phylactou L, Fox JD, Kilpatrick MW, Murray PI (1996) The detection of herpesviral DNA in aqueous fluid samples from patients with Fuchs´ heterochromic cyclitis. Ocular Immunol Inflamm 4: 33–38 Google Scholar
  10. Sundmacher R (1981) A clinico-virologic classification of herpetic anterior segment diseases with special reference to intraocular herpes. In: R Sundmacher (ed) Herpetic eye disease. Bergmann, Munich, pp 203–208 Google Scholar
  11. Sundmacher R (1983) Orale Acyclovir-Therapie virologisch nachgewiesener intraokularer Herpes simplex Virus-Infektionen. Klin Monatsbl Augenheilk 183: 246–250Google Scholar
  12. Sundmacher R (1997) Diagnose und Differentialdiagnose der Endotheliitis und Trabekulitis. In: A Kampik, F Grehn (eds): Entzündungen des Augeninnern. Bücherei des Augenarztes. Enke, Stuttgart, 138: 96–102 Google Scholar
  13. Sundmacher R, Neumann-Haefelin D (1979) Herpes simplex virus-positive and -negative keratouveitis. In: A Silverstein, R O´Connor (eds): Immunology and immunopathology of the eye. Masson, New York / Paris, pp 225–229Google Scholar
  14. Sundmacher R, Neumann-Haefelin D (1979) Herpes-simplex-Virus-Isolierung aus dem Kammerwasser bei fokaler Iritis, Endotheliitis und langdauernder Keratitis disciformis mit Sekundärglaukom. Klin Monatsbl Augenheilk 175: 488–501 Google Scholar
  15. Teitelbaum CS, Streeten BW, Dawson CR (1987) Histopathology of herpes simplex virus keratouveitis. Curr Eye Res 6: 189–194 PubMedGoogle Scholar
  16. Townsend WM, Kaufman HE (1971) Pathogenesis of glaucoma and endothelial changes in herpetic keratouveitis in rabbits. Am J Ophthalmol 71: 904–910 PubMedGoogle Scholar
  17. Vannas A, Ahonen R, Mäkitie J (1983) Corneal endothelium in herpetic keratouveitis. Arch Ophthalmol 101: 913–915 PubMedGoogle Scholar
  18. Weber U, Sundmacher R (1988) Die systemische Acyclovirtherapie herpetischer Sekundärglaukome. Fortschr Ophthalmol 85: 85–87 PubMedGoogle Scholar
  19. Yamamoto S, Pavan-Langston D, Tada R, Yamamoto R, Kinoshita S, Nishida K, Shimomura Y, Tano Y (1995) Possible role of herpes simplex virus in the origin of Posner-Schlossman syndrome. Am J Ophthalmol 119: 796–798 PubMedGoogle Scholar

Section 2.9

  1. Herpetic Eye Disease Study Group (1996) A controlled study of oral acyclovir for iridocyclitis caused by herpes simplex virus. Arch Ophthalmol 114: 1065–1072 Google Scholar
  2. Kaufman HE, Kanai A, Ellison ED: Herpetic iritis (1971) demonstration of virus in the anterior chamber by fluorescent antibody technique and electron microscopy. Am J Ophthalmol 71: 465–469 PubMedGoogle Scholar
  3. Miserocchi E, Waheed NK, Dios E, Christen W, Merayo J, Roque M, Foster CS (2002) Visual outcome in herpes simplex virus and varicella zoster virus uveitis. Ophthalmology 109: 1532–1537 PubMedGoogle Scholar
  4. Schacher S, Garweg JG, Russ C, Böhnke M (1998) Diagnosis of herpetic uveitis and keratouveitis. Klin Monatsbl Augenheilkd 212: 359–362 PubMedGoogle Scholar
  5. Siverio CD, Imai Y, Cunningham ET (2002) Diagnosis and management of herpetic anterior uveitis. Int Ophthalmol Clin 42: 43–48 Google Scholar
  6. Sundmacher R (1981) A clinico-virologic classification of herpetic anterior segment diseases with special reference to intraocular herpes. In: R Sundmacher (ed) Herpetic eye disease. Bergmann, Munich, pp 203–208Google Scholar
  7. Sundmacher R (1981) Die fokale Iritis durch Herpes simplex- und Varizellen-Zoster-Virus. Ber Dtsch Ophthalmol Ges 78: 73–76 Google Scholar
  8. Sundmacher R (1983) Orale Acyclovir-Therapie virologisch nachgewiesener intraokularer Herpes simplex Virus-Infektionen. Klin Monatsbl Augenheilk 183: 246–250 Google Scholar
  9. Sundmacher R, Neumann-Haefelin D (1979) Herpes simplex virus-positive and -negative keratouveitis. In: A Silverstein, R O´Connor (eds): Immunology and immunopathology of the eye. Masson, New York / Paris, pp 225–229.Google Scholar
  10. Sundmacher R, Neumann-Haefelin D (1979) Herpes-simplex-Virus-Isolierung aus dem Kammerwasser bei fokaler Iritis, Endotheliitis und langdauernder Keratitis disciformis mit Sekundärglaukom. Klin Monatsbl Augenheilk 175: 488–501 Google Scholar
  11. Van der Lelij A, Ooijman FM, Kijlstra A, Rothova A (2000) Anterior uveitis with sectoral iris atrophy in the absence of keratitis. A distinct entity among herpetic eye diseases. Ophthalmology 107: 1164–1170 PubMedGoogle Scholar
  12. Witmer R, Iwamoto T (1968) Electron microscopic observation of herpes-like particles in the iris. Arch Ophthalmol 79: 331–337 PubMedGoogle Scholar
  13. Yamamoto S, Pavan-Langston D, Kinoshita S, Nishida K, Shimomura Y, Tano Y (1996) Detecting herpes simplex virus DNA in uveitis using the polymerase chain reaction. Br J Ophthalmol 80: 465–468PubMedGoogle Scholar

Section 2.10

  1. Green LK, Pavan-Langston D (2006) Herpes simplex ocular inflammatory disease. Int Ophthalmol Clin 46: 27–37 PubMedGoogle Scholar
  2. Sainz de la Maza M, Hemady RK, Foster CS (1993) Infectious scleritis: report of four cases. Documenta Ophthalmol 83: 33–41 Google Scholar

Section 2.11

  1. Algan B (1978) Considérations sur la kératite métaherpétique. Klin Monatsbl Augenheilkd 172 : 609–616 Google Scholar
  2. De Haas EBH (1962) Desiccation of cornea and conjunctiva after sensory denervation. Significance of desiccation for pathogenesis of neuroparalytic keratitis. Arch Ophthalmol 67: 79–92Google Scholar
  3. Kaufman HE (1964) Epithelial erosion syndrome: metaherpetic keratitis. Am J Ophthalmol 57: 983–987 PubMedGoogle Scholar
  4. Kaufman HE (1967) Disease of the corneal stroma after herpes simplex infection. Am J Ophthalmol 63: 878–882 PubMedGoogle Scholar
  5. Kaufman HE, Brown DC, Ellison EM (1968) Herpes virus in the lacrimal gland, conjunctiva and cornea of man. Am J Ophthalmol 65: 32–35 PubMedGoogle Scholar
  6. Kok van Alphen CC, Völker-Dieben HJM (1981) Impairment of tear-production in corneal herpetic disease. In: R Sundmacher (ed) Herpetic Eye Diseases. Bergmann, Munich, pp 215–219 Google Scholar
  7. Mackie IA (1978) Role of corneal nerves in destructive disease of the cornea. Trans Ophth Soc UK 98: 343–347Google Scholar
  8. Metcalf JF (1982) Corneal sensitivity and neurohistochemical studies of experimental herpetic keratitis in the rabbit. Exp Eye Res 35: 231–237 PubMedGoogle Scholar
  9. Singh D, Singh M, Singh R, Amritsar (1981) Herpetic keratitis causing lacrimal hyposecretion and xerosis. In: R Sundmacher (ed) Herpetic Eye Diseases. Bergmann, Munich, pp 211–214,Google Scholar
  10. Sundmacher R, Neumann-Haefelin D (1976) Keratitis metaherpetica. Klinische und virologische Befunde. Klin Monatsbl Augenheilk 169: 728–737 Google Scholar
  11. Van Bijsterveld OP, de Koning EWJ (1984) Trophic herpetic corneal ulcers. In: FC Blodi (ed) Herpes Simplex Infections of the Eye. Contemporary Issues in Ophthalmology vol 1. Churchill Livingstone, NY, pp 29–45 Google Scholar

Section 2.12

  1. Ameye C, Maudgal PC, Missotten L (1985) Primary ocular HSV infections in adults. In: PC Maudgal, L Missotten (eds) Herpetic Eye Diseases. Doc Ophthalmol Proc ser 44, pp 133–140 Google Scholar
  2. Beigi B, Algawi K, Foleye-Nolan A, O´Keefe M (1994) Herpes simplex keratitis in children. Br J Ophthalmol 78: 458–460 PubMedGoogle Scholar
  3. Colin J, Le Grignou A, BAikoff G, Chastel C (1980) Three cases of dendritic herpetic ulcerations of the conjunctiva. Am J Ophthalmol 4: 608 Google Scholar
  4. Darougar S, Wishart MS, Vishwalingham ND (1985): Epidemiological and clinical features of primary herpes simplex virus ocular infection. Br J Ophthalmol 69: 2–6 PubMedGoogle Scholar
  5. Ostler HB (1976) Herpes simplex: the primary infection. Surv Ophthalmol 21: 91–99 PubMedGoogle Scholar
  6. Poirier RH (1980) Herpetic ocular infections of childhood. Arch Ophthalmol 98: 704–706 PubMedGoogle Scholar
  7. Sundmacher R (1981) A clinico-virologic classification of herpetic anterior segment diseases with special reference to intraocular herpes. In: R Sundmacher (ed) Herpetic eye diseases. Bergmann, Munich, pp 203–208Google Scholar
  8. Wald A, Benedetti, Davis G, Remington M, Winter C, Corey L (1994) A randomized, double-blind, comparative trial comparing high- and standard-dose oral acyclovir for first-episode genital herpes infections. Antimicrob Agents Chemother 38: 174–176 PubMedGoogle Scholar

Section 2.13

  1. Beyer CF, Hill JM, Reidy JJ, Beuermann RW (1990) Corneal nerve disruption reactivates virus in rabbits latently infected with HSV-1. Invest Ophthalmol Vis Sci 31: 925–932 PubMedGoogle Scholar
  2. Davidorf JM (1998) Herpes simplex keratitis after LASIK. J Refract surg 14: 667 PubMedGoogle Scholar
  3. Dhaliwal DK, Barnhorst DA Jr, Romanowski E, Rehkopf PG, Gordon YJ (1998) Efficient reactivation of latent herpes simplex virus type 1 infection by excimer laser keratectomy in the experimental rabbit ocular model. Am J Ophthalmol 125: 488–492 PubMedGoogle Scholar
  4. Dhaliwal DK, Romanowski EG, Yates KA, Hu DA, Goldstein M, Gordon YJ (2001) Experimental laser-assisted in situ keratomileusis induces the reactivation of latent herpes simplex virus. Am J Ophthalmol 131: 506–507 PubMedGoogle Scholar
  5. Eiferman RA, Adams G, Stower B, Wilkins T (1979) Herpetic whitlow and keratitis. Arch Ophthalmol 97: 1079–1081 PubMedGoogle Scholar
  6. Fagerholm P, Ohman L, Orndahl M (1994) Phototherapeutic keratectomy in herpes simplex keratitis. Clinical results in 20 patients. Acta Ophthalmol 72: 457–460Google Scholar
  7. Hill TJ, Blyth WA, Harbour DA (1978) Trauma to the skin causes recurrence of herpes simplex in the mouse. J Gen Virol 39: 21–28 PubMedGoogle Scholar
  8. Hill TJ, Blyth WA, Harbour DA (1983) Recurrence of herpes simplex in the mouse requires an intact nerve supply to the skin. J Gen Virol 64: 2763–2765 PubMedGoogle Scholar
  9. Holland EJ, Mahanti RL, Belongia EA, Mizener MW, Goodman JL, Andres CW, Osterholm MT (1992) Ocular involvement in an outbreak of herpes gladiatorum. Am J Ophthalmol 114: 680–684 PubMedGoogle Scholar
  10. Jarade EF, Tabbara KF (2001) Laser in situ keratomileusis in eyes with inactive herpetic keratitis. Am J Ophthalmol 132: 779–780 PubMedGoogle Scholar
  11. Levy J, Lapid-Gortzak R, Klemperer I, Lifshitz T (2005) Herpes simplex virus keratitis after laser in situ keratomileusis. J Refract Surg 21: 400–402 PubMedGoogle Scholar
  12. Nesburn AB, Dickinson R, Radnoti M (1976) The effect of trigeminal nerve and ganglion manipulation on recurrences of ocular herpes simplex in rabbits. Invest Ophthalmol Vis Sci 15: 726–731Google Scholar
  13. Nesburn AB, Dickinson R, Radnotti M, Radnotti MT (1976) Experimental reactivation of ocular herpes simplex in rabbits. Surv Ophthalmol 21: 185PubMedGoogle Scholar
  14. Nesburn AB, Green MT, Radnoti M, Walker B (1977) Reliable in vivo model for latent herpes simplex virus reactivation with peripheral virus shedding. Infect Immun 15: 772–775 PubMedGoogle Scholar
  15. Perry HD, Doshi SJ, Donnenfeld ED, Levinson DH, Cameron CD (2002) Herpes simplex reactivation following laser in situ keratomileusis and subsequent perforation. CLAO J 28: 69–71 PubMedGoogle Scholar
  16. Posavad CM, Koelle DM, Corey L (1998) Tipping the scales of herpes simplex virus reactivation: the important responses are local. Nat Med 4: 381–382 PubMedGoogle Scholar
  17. Sundmacher R (1984) Trauma und Herpes. Fortschr Ophthalmol 81: 409–415 PubMedGoogle Scholar
  18. Sundmacher R (1986) Keratitis dendritica nach Hornhautfremdkörper. Klin Monatsbl Augenheilk 188: 307–309 Google Scholar
  19. Wald A, Zeh J, Selke S, Warren T, Ryncarz AJ, Ashley R, Krieger JN, Corey L (2000) Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 342: 844–850 PubMedGoogle Scholar
  20. Zheng X, Loutsch JM, Shimomura Y, Gebhardt BM, Hill JM, Kaufman HE (1999) Reactivation of herpes virus after lamellar keratoplasty. Jpn J Ophthalmol 43: 257–261 PubMedGoogle Scholar

Section 2.14

  1. Alino AM, Perry HD, Kanellopoulos AJ, Donnenfeld ED, Rahn EK (1998) Conjunctival flaps. Ophthalmology 105: 1120–1123 PubMedGoogle Scholar
  2. Barequet IS, Wasserzug Y (2007) Herpes simplex keratitis after cataract surgery. Cornea 26: 615–617 PubMedGoogle Scholar
  3. Beyer CF, Byrd TI, Hill JM, Kaufman HE (1990) Herpes simplex virus and persistent epithelial defects after penetrating keratoplasty. Am J Ophthalmol 109: 95–96 PubMedGoogle Scholar
  4. Birnbaum F, Reinhard T, Ulbricht T, Haußer J, Sundmacher R (2004) Funktionelle Ergebnisse nach autologer Rotationskeratoplastik. Eine retrospektive Analyse. Ophthalmologe 101: 54–58 PubMedGoogle Scholar
  5. Birnbaum F, Reinhard T, Böhringer D, Sundmacher R (2005) Endothelial cell loss after autologous rotational keratoplasty. Albrecht von Graefes Arch Clin Exp Ophthalmol 243: 57–59 Google Scholar
  6. Böhringer D, Reinhard T (2008) Prognosis in repeat keratoplasty: per indication analysis in a large monocentric cohort. Klin Monatsbl Augenheilkde 225: 50–56 Google Scholar
  7. Böhringer D, Sundmacher R, Reinhard T (2007) HLA B27 sems to promote graft failure following penetrating keratoplasties for herpetic corneal scars. Ophthalmologe 104: 705–708 PubMedGoogle Scholar
  8. Böhringer D, Sundmacher R, Reinhard T (2006) Histocompatibility matching in penetrating keratoplasty. In: T Reinhard, F Larkin (vol–eds): Esssentials in ophthalmology: Cornea and external eye disease. Springer, Berlin – Heidelberg – NY, pp 101–108Google Scholar
  9. Borderie VM, Méritet JF, Chaumeil C, Rozenberg F, Baudrimont M, Touzeau O, Bourcier T, Laroche L (2004) Culture-proven herpetic keratitis after penetrating keratoplasty in patients with no previous history of herpes disease. Cornea 23: 118–124 PubMedGoogle Scholar
  10. Cheng C-K, Chang S-W, Hu F-R (1995) Acyclovir treatment for linear endotheliitis on grafted corneas. Cornea 14: 311–315 PubMedGoogle Scholar
  11. Dana MR, Streilein JW (1996) Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest Ophthalmol Vis Sci 37: 2485–2494 PubMedGoogle Scholar
  12. Engelskirchen U, Sundmacher R (1990) Aufklebung harter Kontaktlinsen als Notfallmaßnahme bei drohender Hornhautperforation. Sitzungsbericht 152. Versammlung Rhein.-Westf. Augenärzte: 247–251 Google Scholar
  13. Garweg J, Böhnke M (1996) Slow viral replication of HSV-1 is responsible for early recurrence of herpetic keratitis after corneal grafting. Albrecht von Graefes Arch Clin Exp Ophthalmol 234 Suppl 1: S133–S138 Google Scholar
  14. Heiligenhaus A, Li H, Hernandez Galindo EE, Koch JM, Steuhl KP, Meller D (2003) Management of acute ulcerative and necrotizing herpes simplex and zoster keratitis with amniotic membrane transplantation. Br J Ophthalmol 87: 1215–1219 PubMedGoogle Scholar
  15. Heiligenhaus A, Li H, Yang Y, Wasmuth S, Bauer D, Steuhl KP (2004) Amniotic membrane transplantation improves experimental herpetic keratitis. Modulation of matrix metalloproteinase-9. Ophthalmologe 101: 59–65 PubMedGoogle Scholar
  16. Kersten A, Sundmacher R, Reinhard T (1997) Postoperative Komplikationen nach perforierender Keratoplastik in Herpesaugen. Differentialdiagnose, Therapie und prognostische Bedeutung. Ophthalmologe 94: 889–896 PubMedGoogle Scholar
  17. Khodadoust A, Quinter AP (2003) Microsurgical approach to the conjunctival flap. Arch Ophthalmol 121:1189–1193 PubMedGoogle Scholar
  18. Kirkness CM, Adams GG, Dilly PN, Lee JP (1988) Botulinum toxin A-induced protective ptosis in corneal disease. Ophthalmology 95: 473–480 PubMedGoogle Scholar
  19. Kruse FE, Rohrschneider K, Völcker HE (1999) Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers. Ophthalmology 106: 1504–1510 PubMedGoogle Scholar
  20. Mackensen G, Haug P, Horn C, Sundmacher R, Witschel H (1978) Nahtlockerung nach Keratoplastik und Korrekturmöglichkeiten. Klin Monatsbl Augenheilk 173: 700–707 Google Scholar
  21. Mannis MJ, Plotnik RD, Schwab IR, Newton RD (1991) Herpes simplex dendritic keratitis after keratoplasty. Am J Ophthalmol 111: 480–484 PubMedGoogle Scholar
  22. Marx W, Madjlessi F, Reinhard T, Althaus C, Sundmacher R (1999) Mehr als vier Jahre Erfahrung mit der elektronischen intraokularen Nadel-Druckmessung bei irregulären Hornhäuten. Ophthalmologe 96: 498–502 PubMedGoogle Scholar
  23. Mayer K, Reinhard T, Reis A, Voiculescu A, Sundmacher R (2003) Synergistic effect of acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease. Albrecht von Graefes Arch Clin Exp Ophthalmol 241: 1051–1054 Google Scholar
  24. Mietz H, Cassinotti P, Siegl G, Kirchhof B, Krieglstein GK (1995) Detection of herpes simplex virus after penetrating keratoplasty by polymerase chain reaction: correlation of clinical and laboratory findings. Albrecht von Graefes Arch Clin Exp Ophthalmol: 233: 714–716 Google Scholar
  25. Reinhard T, Böhringer D, Sundmacher R (2001) Accelerated chronic endothelial cell loss after penetrating keratoplasty in glaucoma eyes. J Glaucoma 10: 446–451 PubMedGoogle Scholar
  26. Reinhard T, Kallmann C, Cepin A, Godehardt E, Sundmacher R (1997) The influence of glaucoma history on graft survival after penetrating keratoplasty. Albrecht von Graefes Arch Clin Exp Ophthalmol 235: 553–557 Google Scholar
  27. Reis A, Reinhardt T (2006) Current systemic immunosuppressive strategies in penetrating keratoplasty. In: T Reinhard, F Larkin (vol–eds): Esssentials in ophthalmology: Cornea and external eye disease. Springer, Berlin – Heidelberg – NY, pp 109–122Google Scholar
  28. Reis A, Reinhard T, Voiculescu K, Mayer K, Sundmacher R (2001) Hochaktive antivirale und immunsuppressive Kombinationstherapie mit Acyclovir und Mycophenolatmofetil nach Keratoplastik mit herpetischer Grunderkrankung. Klin Monatsbl Augenheilk 218: 183–186 Google Scholar
  29. Remeijer L, Doornenbal P, Geerards AJ, Rijneveld WA, Beekhuis WH (1997) Newly acquired herpes simplex virus keratitis after penetrating keratoplasty. Ophthalmology 104: 648–652 PubMedGoogle Scholar
  30. Rezende RA, Bisol T, Hammersmith K, Hofling–Lima AL, Webster GF, Freitas JF, Rapuano CJ, Laibson PR, Cohen EJ (2007) Epithelial herpes simplex keratitis recurrence and graft survival after corneal transplantation in patients with and without atopy. Am J Ophthalmol 143: 623–628 PubMedGoogle Scholar
  31. Rezende RA, Uchoa UB, Raber IM, Rapuano CJ, Laibson PR, Cohen EJ (2004) New onset of herpes simplex virus epithelial keratitis after penetrating keratoplasty. Am J Ophthalmol 137: 415–419 PubMedGoogle Scholar
  32. Richter A, Slowik C, Somodi S, Vick HP, Guthoff R (1997) Corneal reinnervation following penetrating keratoplasty. Correlation of esthesiometry and confocal microscopy. Ger J Ophthalmol 5: 513–517 Google Scholar
  33. Sengler U, Spelsberg H, Reinhard T, Sundmacher R, Adams O, Auw-Hädrich C, Witschel H (1999) Herpes simplex virus (HSV-1) infection in a donor cornea. Br j Ophthalmol 83: 1405 PubMedGoogle Scholar
  34. Sengler U, Reinhard T, Adams O, Krempe C, Sundmacher R (2001) Herpes–simplex–virus infection in donor corneae during organ culture –frequency and consequences. Eye 15: 644–647 PubMedGoogle Scholar
  35. Seitz B (2007) Amnionmembrantransplantation. Eine unverzichtbare Therapieoption bei persistierenden kornealen Epitheldefekten. Ophthalmologe 104: 1075–1079 PubMedGoogle Scholar
  36. Shi W, Chen M, Xie L (2007) Amniotic membrane transplantation combined with antiviral and steroid therapy for herpes necrotizing stromal keratitis. Ophthalmology 114: 1476–1481 PubMedGoogle Scholar
  37. Shimomura Y, Deai T, Fukuda M, Higaki S, Hooper LC, Hayashi K (2007) Corneal buttons obtained from patients with HSK harbor high copy numbers of the HSV genome. Cornea 26: 190–193PubMedGoogle Scholar
  38. Simon AL, Pavan–Langston D (1996) Long-term oral acyclovir therapy. Effect on recurrent infectious herpes simplex keratitis in patients with and without grafts. Ophthalmology 103: 1399–1404 PubMedGoogle Scholar
  39. Spelsberg H, Reichelt JA (2008) Amniotic membrane transplantation in proven ulcerative herpetic keratitis: successful anti-inflammatory treatment in time. Klin Monatsbl Augenheilkde 225: 75–79 Google Scholar
  40. Stanojlovic S, Schlickeiser S, Pleyer U (2008) Keratoplasty in HSV keratitis: prevention and therapy for immunologic complications. Klin Monatsbl Augenheilkd 225: 22–29 PubMedGoogle Scholar
  41. Sterk CC, Jager MJ, Swart-vd Berg (1995) Recurrent herpetic keratitis in penetrating keratoplasty. Doc Ophthalmol 90: 29–33 PubMedGoogle Scholar
  42. Stübinger N, Pleyer U, Erb C, Thiel HJ (1995) Keratoplasty à chaud. Ophthalmologe 92: 427–432 Google Scholar
  43. Sundmacher R (1997) Immunreaktionen nach Keratoplastik. Klin Monatsbl Augenheilk 171: 705–722 Google Scholar
  44. Sundmacher R (1981) Differential diagnosis of post–keratoplasty complications in herpes patients. In: R Sundmacher (ed) Herpetic eye disease. Bergmann, Munich, pp 439–444Google Scholar
  45. Sundmacher R (1995) Die Vorteile der doppelten fortlaufenden Kreuzstichnaht gegenüber der einfach fortlaufenden Naht bei perforierender Keratoplastik. Klin Monatsbl Augenheilk 207: 342–343 Google Scholar
  46. Sundmacher R (ed) (2003) Adequate HLA matching in keratoplasty. Dev Ophthalmol vol 36. Karger, Basel – Sydney, pp 100 Google Scholar
  47. Sundmacher R, Ameye C (1989) Keratoplastik und Kapselsacklinseneinpflanzung bei Herpespatienten. In: GK Lang et al (eds): 2. DGII–Kongress. Enke, Stuttgart, pp 106–109Google Scholar
  48. Sundmacher R, Reinhard T, Kersten A: Intraokularlinsen-Implantation bei Herpeserkrankung des Auges. In: 12. Kongress der DGII (Duncker et al, eds) Springer, Berlin – Heidelberg – New York, pp 76–71 (1998)Google Scholar
  49. Sundmacher R, Müller O (1983) Endothelzellverluste nach Keratoplastik. Spiegelmikroskopische Verlaufsbeobachtungen bei Immunreaktionen gegen Transplantatendothel. Klin Monatsbl Augenheilk 182: 86–90 Google Scholar
  50. Sundmacher R, Stefansson A, Mackensen G (1983) Verlaufsbeobachtungen nach Keratoplastik. Fortschr Ophthalmol 80: 224–227 PubMedGoogle Scholar
  51. Sundmacher R, Wolff M (1993) Four years´ experience with triple procedures in herpes eyes. German J Ophthalmol 2: 65–69 Google Scholar
  52. Tei M, Nishida K, Kinoshita S (1996) Polymerase chain reaction detection of herpes simplex virus in tear fluid from atypical herpetic epithelial keratitis after penetrating keratoplasty. Am J Ophthalmol 122: 732–735PubMedGoogle Scholar
  53. Van Gelderen BE, van der Lelij A, Treffers WF, van der Gaag R (2000) Detection of herpes simplex virus type 1, 2 and varicella zoster virus DNA in recipient corneal buttons. Br J Ophthalmol 84: 1238–1243PubMedGoogle Scholar
  54. Van Rooij J, Rijneveld WJ, Remeijer L, Völker–Dieben HJ, Eggink CA, Geerards AJ, Mulder PG, Doornenbal P, Beekhuis WH (2003) Effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis: a placebo-controlled multicenter trial. Ophthalmology 110: 1916–1919PubMedGoogle Scholar
  55. Völker-Dieben HJ, Claas FH, Schreuder GM, Schipper RF, Pels E, Persijn GG, Smits J, D´Amaro J (2000) Beneficial effect of HLA-DR matching on the survival of corneal allografts. Transplantation 70: 640–648 PubMedGoogle Scholar
  56. Zheng X, Marquart ME, Loustch JM, Shah P, Sainz B, Ray A, O´Callaghan RJ, Kaufman HE, Hill JM (1999) HSV-1 migration in latently infected and naive rabbits after penetrating keratoplasty. Invest Ophthalmol Vis Sci 40: 2490–2497 PubMedGoogle Scholar

Section 2.15

  1. Freeman ML, Sheridan BS, Bonneau RH, Hendricks RL (2007) Psychological stress compromises CD8 + T cell control of latent herpes simplex type 1 infections. J Immunol 179: 322328 PubMedGoogle Scholar
  2. Herpetic Eye Disease Study Group (1997) A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with epithelial keratitis. The epithelial keratitis trial. Arch Ophthalmol 115: 703712 Google Scholar
  3. Herpetic Eye Disease Study Group (1998) Acyclovir for the prevention of recurrent herpes simplex virus eye diseases. N Engl J Med 339: 300–306 Google Scholar
  4. Herpetic Eye Disease Study Group (2000) Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Arch Ophthalmol 118: 10301036 Google Scholar
  5. Herpetic Eye Disease Study Group (2001) Predictors of recurrent herpes simplex virus keratitis. Cornea 20: 123128 Google Scholar
  6. Lairson KR, Begley CE, Reynolds TF, Wilhelmus KR (2003) Prevention of herpes simplex virus eye disease: a cost effectiveness analysis. Arch Ophthalmol 121: 108112 PubMedGoogle Scholar
  7. Mascola JR (1999) Herpes simplex virus vaccines – why don´t antibodies protect? (editorial). JAMA 282: 379380 PubMedGoogle Scholar
  8. Nesburn AB, Wiley DE, Trousdale MD (1983) Effect of intensive acyclovir therapy during artificial reactivation of latent herpes simplex virus. Proc Soc Exp Biol Med 72: 316320 Google Scholar
  9. Pepose JS, Keadle TL, Morrison LA (2006) Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy. Am J Ophthalmol 141: 547557 PubMedGoogle Scholar
  10. Rezende RA, Bisol T, Hammersmith K, Rapuano CJ, Lima AL, Webster GF, Freitas JF, Laibson PR, Cohen EJ (2006) Efficacy or oral antiviral prophylaxis in preventing ocular herpes simplex virus recurrences in patients with and without self-reported atopy. Am J Ophthalmol 142: 563567 PubMedGoogle Scholar
  11. Rodriguez A, Power WJ, Neves RA, Foster CS (1995) Recurrence rate of herpetic uveitis in patients on long-term oral acyclovir. Doc Ophthalmol 90: 331340 PubMedGoogle Scholar
  12. Shuster JJ, Kaufman HE, Nesburn AB (1981) Statistical analysis of the rate of recurrence of herpesvirus ocular epithelial disease. Am J Ophthalmol 91: 328331 PubMedGoogle Scholar
  13. Simon AL, Pavan–Langston D (1996) Long-term oral acyclovir therapy. Effect on recurrent infectious herpes simplex keratitis in patients with and without grafts. Ophthalmology 103: 13991404 PubMedGoogle Scholar
  14. Sundmacher R (1978) Trifluorthymidinprophylaxe bei der Steroidtherapie herpetischer Keratouveitiden. Klin Monatsbl Augenheilk 173: 516519 Google Scholar
  15. Sundmacher R, Cantell K, Haug P, Neumann–Haefelin D (1978) Interferon Prophylaxe von Dendritica–Rezidiven bei lokaler Steroidtherapie. Ber Dtsch Ophthalmol Ges 75: 569570 Google Scholar
  16. Sundmacher R, Neumann-Haefelin D, Cantell K (1981) Therapy and prophylaxis of dendritic keratitis with topical human interferon. In: R Sundmacher (ed): Herpetic eye disease. Bergmann, Munich, pp 401407Google Scholar
  17. Uchoa UB, Rezende RA, Carrasco MA, Rapuano CJ, Laibson PR (2003) Long term acyclovir use to prevent recurrent ocular herpes simplex virus infection. Arch Ophthalmol 121: 1702–1704PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  • Rainer Sundmacher
    • 1
  1. 1.University Eye HospitalDüsseldorfGermany

Personalised recommendations